• GPI Home
  • Solutions
    • GPI pulse™
    • GPI Consulting
    • GPI Horizon Methodology
    • Case Studies
  • About Us
    • Our Team
    • Careers
  • Contact Us
  • Discover
    • Blog
    • Events
    • Resources
  • GPI Direct
Month: March 2020
GPI - Despite Current Uncertainty GPI's agile solutions can help ensure P&MA continuity. Get in touch to find out more!
March 24, 2020 by Global Pricing Innovations (GPI)
Currently adapting to the new COVID-19 era? GPI can support you in ensuring P&MA continuity

By Dimitra Sotou, Senior Consultant, Pricing & Market Access Day 1 of official lockdown today, and increasingly more organizations around the globe are facing tighter operational restrictions due to the COVID-19 outbreak – Name it: day-to-day work, restricted travel, team meetings, cancelled conferences,…

March 20, 2020 by Global Pricing Innovations (GPI)
UPDATED – Webinar: Early Price and Access Forecasting (WFH Edition)

We hope you are all safe and in good health. At GPI, we are extremely proud to present our new offering, GPI HORIZON, an innovative methodology supporting early price and access forecasting. Despite the uncertainty and change brought by COVID-19 outbreak, GPI have…

SiSense Logo
March 17, 2020 by Global Pricing Innovations (GPI)
GPI makes market access more efficient with pioneering partnership with Sisense-enabled analytics platform

Pricing & Market Access leader enhances pricing database with world’s leading analytics platform for technology developers  London, UK, March 17, 2020 – Global Pricing Innovations (GPI), a leader in analytical market access solutions for biopharma, has announced the Spring 2020 release of new features…

March 10, 2020 by Global Pricing Innovations (GPI)
Spain introduces exclusive pricing scheme for new orphan drugs. How will this affect International Reference Pricing?

Author – Nairuti Patel (Associate Consultant, GPI) On 3rd March 2020, the Spanish Council of Ministers announced a ‘specific pricing system’ for orphan medicinal product that will be separate from the reference pricing system. The reference pricing system applies to all other products reimbursed by the Spanish National Health System (SNS) when their patent has expired. The only instance when orphan drugs will be included in this new…

GPI Pulse used in Spain
Lower Drug Costs
March 4, 2020 by Global Pricing Innovations (GPI)
U.S. House passed an ambitious bill to lower drug prices

At the end of 2019, important legislative changes took place in the United States that could impact the country’s pharmaceutical industry over the coming years. The U.S. House of Representatives has passed the Lower Drug Costs Now Act on 12th December 2019, setting…

March 3, 2020 by Global Pricing Innovations (GPI)
Canada moved further to tackle high drug prices as Patented Medicines Prices Review Board (“PMPRB”) released new draft Guidelines for consultation

By Pramod Kumar Mali, Senior Business Analyst Back in August 2019, GPI reported the new regulations finalized by Canada to tackle high drug prices by making amendments to the Patented Medicines Regulations. On November 21, 2019, the Patented Medicines Prices Review Board (“PMPRB”)…

GPI in Canada
Our partners
  • Privacy Policy
  • Terms of Use

| © Copyright 2018 Global Pricing Innovations. All Rights Reserved.

VAT registration: GB225169121